Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 22 results found. Search for [ Saumen Chakraborty ]

Results 1 to 21 of 22
E Kumar Sharma
May 24, 2018
Analysts read several things into it. First, they linked it to the fact that there was no negative shock especially in the US part of the business. There was a negative in the performance in Russia, an important contributor to the profitability of the company.

May 22, 2018

E Kumar Sharma
January 26, 2018
A day earlier, the company had informed the bourses that a re-inspection carried out by the German regulator at the company's formulations making plant at Bachupally, Hyderabad, had led to the EU GMP non-compliance getting withdrawn by the government of Bavaria and this means the plant could restart dispatching its approved products to the European Union.

E. Kumar Sharma
New Delhi, June 10, 2017
Dr. Reddy's says it has a plan and a product pipeline to drive growth in spite of regulatory and other challenges. Can it pull it off?

Mumbai, July 27, 2016
At NSE, shares of the company plunged 10.22 per cent to end at Rs 2,980.20. The stock was the biggest loser among the bluechips on both Sensex and Nifty during the day. The company's market valuation dipped by Rs 5,529.15 crore to Rs 49,473.85 crore.

E Kumar Sharma
July 26, 2016
Afterall, its net profit for the quarter was down 80 per cent PAT touching Rs 126.3 crore as against Rs 625.7 crore in the corresponding period of the previous year.

E Kumar Sharma
May 13, 2016
Till it starts getting approvals for new product launches in the US market, analysts see tough times continuing for Dr Reddy's, the Hyderabad-headquartered, NYSE-listed Indian pharma major.

By E. Kumar Sharma
Delhi, April 25, 2016
In the third quarter, Dr. Reddy's revenues from India rose 34 per cent from the corresponding quarter of the previous year (partly due to acquisition of a few established brands of Belgian company UCB in India). However, in March, the growth was 7 per cent.

E Kumar Sharma
November 25, 2015

BT Online
New Delhi, November 6, 2015
The stock fell after the drug major received a warning letter from US FDA on their API manufacturing facilities at Srikakulam and Oncology formulation facility at Duvvada in Andhra Pradesh.

BT Online Bureau
New Delhi, July 31, 2015
Capital infusion in banks and expectations of a rate cut by the apex bank cheered investor sentiments. Here are the five stocks that remained in news today.

E. Kumar Sharma
July 30, 2015
There were two important growth drivers for the company. One, the 8 per cent year-on-year growth in its global generics business, which were primarily driven by North America; and two, good growth shown in its India business.

E. Kumar Sharma
May 12, 2015
The company's revenues touched Rs 3,870 crore, a year-on-year growth of 11 per cent and for FY 15 the revenues stood at Rs 14,820 crore, a year-on-year growth of 12 per cent.

Zeba Siddiqui
Mumbai, November 12, 2014
Leading generic drugmakers Dr Reddy's Labs and Glenmark Pharma in November posted a drop in their second-quarter US sales, blaming the slowdown in the approval process.

E Kumar Sharma
October 13, 2014
\"We have about 100 branches in Vizag area. However, we're not able to operate 56 of these branches as there is no connectivity to our server\", said CMD of Andhra Bank.

Arunima Mishra
October 22, 2014
The fifth edition of the Business Today-YES Bank Best CFO awards recognised India's top financial brains, who successfully navigated their companies out of a difficult year.

E. Kumar Sharma
September 29, 2014
Keep debt low and do not take high financial risks - these are the success mantras of Saumen Chakraborty, the overall winner of this year's BT-YES Bank Best CFOs Survey.

Mahesh Nayak
September 25, 2014
\"Though risk management will continue to remain in focus, the hopes of an expected revival will see CFOs starting to take risks...\" says L&T CFO R Shankar Raman.
September 22, 2014
Why CFOs rarely become CEOs and how they can
September 20, 2014
Dr Reddy's CFO Saumen Chakraborty says CFOs in the pharma industry should not take too much financial risk. A CFO should drive business performance and create more value for the organisation.

PAGES 1 OF 2  12